比較リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：世界の体外式膜型人工肺（ECMO）市場：モダリティ別、用途別、患者別、産業分析レポート、地域市場の見通し、用途可能性、価格動向、競合市場シェア、予測
市場調査レポート
商品コード
701216

世界の体外式膜型人工肺（ECMO）市場：モダリティ別、用途別、患者別、産業分析レポート、地域市場の見通し、用途可能性、価格動向、競合市場シェア、予測

Extracorporeal Membrane Oxygenation Market Size By Modality, By Application, By Patient Population, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 150 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.33円
世界の体外式膜型人工肺（ECMO）市場：モダリティ別、用途別、患者別、産業分析レポート、地域市場の見通し、用途可能性、価格動向、競合市場シェア、予測
出版日: 2021年07月15日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の体外式膜型人工肺、通称ECMO(エクモ) 市場について調査分析を行い、市場概要、市場動向などについて考察するとともに、モダリティ別、用途別、患者別、地域別に市場を分析、主な企業のプロファイルなどについて包括的にまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 体外式膜型人工肺（ECMO）産業の考察

  • 産業セグメンテーション
  • 産業の状況
  • 産業影響因子
  • 成長性分析
  • 規制の状況
  • ファイブフォース分析
  • 競合状況
  • PESTEL分析

第4章 体外式膜型人工肺（ECMO）市場：モダリティ別

  • 体外式膜型人工肺（ECMO）市場シェア：モダリティ別
  • 静脈・動脈 (VA) 方式
  • 静脈・静脈 (VV) 方式
  • 動脈・静脈 (AV) 方式

第5章 体外式膜型人工肺（ECMO）市場：用途別

  • 体外式膜型人工肺（ECMO）市場シェア：用途別
  • 心臓疾患
  • 呼吸器疾患
  • 体外循環式心肺蘇生 (ECPR)

第6章 体外式膜型人工肺（ECMO）市場：患者別

  • 体外式膜型人工肺（ECMO）市場シェア：患者別
  • 乳幼児
  • 小児
  • 成人

第7章 体外式膜型人工肺（ECMO）市場：地域別

  • 体外式膜型人工肺（ECMO）市場シェア：地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東/アフリカ

第8章 企業プロファイル

  • Abbott Laboratories
  • Alung Technologies
  • Braile Biomedic
  • Edwards Lifesciences Corp
  • Elsius Biomedical Inc.
  • Eurosets Srl
  • Getinge Group
  • LivaNova PLC
  • Medtronic Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Origen Biomedical
  • Spectrum Medical
  • Terumo Corporation

データ表

図表

Data Tables

  • TABLE 1. ECMO market, 2016 - 2020 (USD Million)
  • TABLE 2. ECMO market, 2021 - 2027(USD Million)
  • TABLE 3. ECMO market, by type, 2016 - 2020 (USD Million)
  • TABLE 4. ECMO market, by type, 2021 - 2027 (USD Million)
  • TABLE 5. ECMO market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 6. ECMO market, by end-use, 2021 - 2027(USD Million)
  • TABLE 7. ECMO market, by region, 2016 - 2020 (USD Million)
  • TABLE 8. ECMO market, by region, 2021 - 2027(USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Venoarterial (VA) market size, by region, 2016 - 2020 (USD Million)
  • TABLE 11. Venoarterial (VA) market size, by region, 2021 - 2027(USD Million)
  • TABLE 12. Veno-venous (VV) market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13. Veno-venous (VV) market size, by region, 2021 - 2027(USD Million)
  • TABLE 14. Arteriovenous (AV) market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15. Arteriovenous (AV) market size, by region, 2021 - 2027(USD Million)
  • TABLE 16. Cardiac disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17. Cardiac disease market size, by region, 2021 - 2027(USD Million)
  • TABLE 18. Respiratory disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19. Respiratory disease market size, by region, 2021 - 2027(USD Million)
  • TABLE 20. Infant market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21. Infant market size, by region, 2021 - 2027(USD Million)
  • TABLE 22. Pediatric disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23. Pediatric disease market size, by region, 2021 - 2027(USD Million)
  • TABLE 24. Adult disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25. Adult disease market size, by region, 2021 - 2027(USD Million)
  • TABLE 26. ECPR market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27. ECPR market size, by region, 2021 - 2027(USD Million)
  • TABLE 28. North America ECMO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 29. North America ECMO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 30. North America ECMO market size, by Product, 2016 - 2020 (USD Million)
  • TABLE 31. North America ECMO market size, by product, 2021 - 2027 (USD Million)
  • TABLE 32. North America ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 33. North America ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 34. North America ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 35. North America ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 36. North America ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 37. North America ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 38. U.S. ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 39. U.S. ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 40. U.S. ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 41. U.S. ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 42. U.S. ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 43. U.S. ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 44. Canada ECMO market size, by Modality, 2016 - 2020 (USD Million)
  • TABLE 45. Canada ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 46. Canada ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 47. Canada ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 48. Canada ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 49. Canada ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 50. Europe ECMO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 51. Europe ECMO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 52. Europe ECMO market size, by Modality, 2016 - 2020 (USD Million)
  • TABLE 53. Europe ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 54. Europe ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 55. Europe ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 56. Europe ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 57. Europe ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 58. Germany ECMO market size, by Modality, 2016 - 2020 (USD Million)
  • TABLE 59. Germany ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 60. Germany ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 61. Germany ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 62. Germany ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 63. Germany ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 64. UK ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 65. UK ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 66. UK ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 67. UK ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 68. UK ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 69. UK ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 70. France ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 71. France ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 72. France ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 73. France ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 74. France ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 75. France ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 76. Italy ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 77. Italy ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 78. Italy ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 79. Italy ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 80. Italy ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 81. Italy ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 82. Spain ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 83. Spain ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 84. Spain ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 85. Spain ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 86. Spain ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 87. Spain ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 88. Asia Pacific ECMO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 89. Asia Pacific ECMO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 90. Asia Pacific ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 91. Asia Pacific ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 92. Asia Pacific ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 93. Asia Pacific ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 94. Asia Pacific ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 95. Asia Pacific ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 96. India ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 97. India ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 98. India ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 99. India ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 100. India ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 101. India ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 102. China ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 103. China ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 104. China ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 105. China ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 106. China ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 107. China ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 108. Japan ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 109. Japan ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 110. Japan ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 111. Japan ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 112. Japan ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 113. Japan ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 114. Taiwan ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 115. Taiwan ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 116. Taiwan ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 117. Taiwan ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 118. Taiwan ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 119. Taiwan ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 120. Latin America ECMO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 121. Latin America ECMO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 122. Latin America ECMO market size, by Modality, 2016 - 2020 (USD Million)
  • TABLE 123. Latin America ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 124. Latin America ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 125. Latin America ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 126. Latin America ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 127. Latin America ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 128. Brazil ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 129. Brazil ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 130. Brazil ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 131. Brazil ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 132. Brazil ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 133. Brazil ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 134. Mexico ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 135. Mexico ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 136. Mexico ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 137. Mexico ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 138. Mexico ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 139. Mexico ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 140. Argentina ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 141. Argentina ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 142. Argentina ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 143. Argentina ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 144. Argentina ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 145. Argentina ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 146. Middle East & Africa ECMO market size, by country, 2016 - 2020 (USD Million)
  • TABLE 147. Middle East & Africa ECMO market size, by country, 2021 - 2027 (USD Million)
  • TABLE 148. Middle East & Africa ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 149. Middle East & Africa ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 150. Middle East & Africa ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 151. Middle East & Africa ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 152. Middle East & Africa ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 153. Middle East & Africa ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 154. South Africa ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 155. South Africa ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 156. South Africa ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 157. South Africa ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 158. South Africa ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 159. South Africa ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 160. Saudi Arabia ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 161. Saudi Arabia ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 162. Saudi Arabia ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 163. Saudi Arabia ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 164. Saudi Arabia ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 165. Saudi Arabia ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 166. Qatar ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 167. Qatar ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 168. Qatar ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 169. Qatar ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 170. Qatar ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 171. Qatar ECMO market size, by patient population, 2021 - 2027 (USD Million)
  • TABLE 172. UAE ECMO market size, by modality, 2016 - 2020 (USD Million)
  • TABLE 173. UAE ECMO market size, by modality, 2021 - 2027 (USD Million)
  • TABLE 174. UAE ECMO market size, by application, 2016 - 2020 (USD Million)
  • TABLE 175. UAE ECMO market size, by application, 2021 - 2027 (USD Million)
  • TABLE 176. UAE ECMO market size, by patient population, 2016 - 2020 (USD Million)
  • TABLE 177. UAE ECMO market size, by patient population, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 ECMO industry 360 degree synopsis
  • FIG. 2 Industry segmentation
  • FIG. 3 Global ECMO market, 2016 - 2027 (USD Million)
  • FIG. 4 Growth potential analysis, by modality
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by patient population
  • FIG. 7 Porter's analysis
  • FIG. 8 PESTEL analysis
  • FIG. 9 Key segment trends, by modality
  • FIG. 10 Key segment trends, by application
  • FIG. 11 Key segment trends, by patient population
  • FIG. 12 Key regional trends
  • FIG. 13 Competitive dashboard, 2020
目次
Product Code: 2720

The extracorporeal membrane oxygenation (ECMO) market is expected to witness rapid growth by 2027 owing to rising utilization in cases of respiratory failure or distress across the globe. Moreover, soaring prevalence of illnesses that damage the heart and lungs is projected to further support market growth through the forecast timeline.

Extracorporeal membrane oxygenation (ECMO), a life support machine, is utilized for people suffering from a severe and life-threatening illness that hampers the functioning of their heart or lungs. The novel coronavirus, which has ravaged the entire world, severely affects the respiratory systems of patients, causing them to develop conditions like acute respiratory distress syndrome (ARDS).

During the COVID-19 pandemic, leading health agencies like the WHO recommended the use of extracorporeal membrane oxygenation (ECMO) in patients with ARDS, which bolstered research focus to establish its efficacy.

For instance, a February 2021 study published in Intensive Care Medicine estimated the effects of ECMO on COVID-19 mortality. The research findings indicated that ECMO could help reduce mortality in select COVID-19 patients with severe respiratory failure. As a result, growing significance of ECMO in improving patient outcomes during the pandemic has positively impacted industry outlook globally.

For extensive assessment, the extracorporeal membrane oxygenation (ECMO) market has been categorized in terms of modality, application, patient population, and region. On the basis of modality, the market has further been divided into veno-venous (VV), venoarterial (VA), and arteriovenous (AV).

The veno-venous (VV) sub-segment is anticipated to grow at a robust pace to reach a considerable valuation by the end of 2027. Benefits of VV ECMO for patients in need of temporary lung assistance and cardiopulmonary support are slated to impel segmental adoption through the forthcoming years.

From the application perspective, the market has been segregated into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory sub-segment is estimated to see significant growth by 2027, registering a steady CAGR over the analysis period. Proliferating demand for respiratory assistance devices among COVID-19 patients is set to augment market demand across the globe.

With respect to patient population, the market has been segmented into pediatric, infant, and adult. In 2020, the adult sub-segment held around 40% share in the extracorporeal membrane oxygenation (ECMO) market revenue and is calculated to expand at a stable pace over 2021-2027.

Substantial increase in requirement of ECMO procedures among adults is likely to fuel segmental expansion. Moreover, high susceptibility of the geriatric populace to COVID-19 is foreseen to facilitate market adoption in the coming years.

Based on region, North America accounted for over 60% of the extracorporeal membrane oxygenation (ECMO) market in 2020 and is expected to garner a notable revenue by the end of the study timeframe. Increasing purchasing power of consumers, coupled with the presence of numerous ECMO centers in the U.S., is speculated to propel regional market growth in the future.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Extracorporeal membrane oxygenation industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Extracorporeal Membrane Oxygenation Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing cases of cardiopulmonary disease and respiratory failure in Asia Pacific
      • 3.3.1.2 Technological advancements
      • 3.3.1.3 Increasing incidence of infectious diseases
      • 3.3.1.4 Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation device in Latin America
      • 3.3.1.5 Rising government initiatives and programs in Europe
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of equipment
      • 3.3.2.2 Dearth of skilled professionals
      • 3.3.2.3 Risks related to ECMO devices
  • 3.4 Growth potential analysis
    • 3.4.1 By modality
    • 3.4.2 By application
    • 3.4.3 By patient population
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
  • 3.9 PESTEL analysis

Chapter 4 Extracorporeal Membrane Oxygenation Market, By Modality

  • 4.1 Key segment trends
  • 4.2 Venoarterial (VA)
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Veno-venous (VV)
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Arteriovenous (AV)
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Extracorporeal Membrane Oxygenation Market, By Application

  • 5.1 Key segment trends
  • 5.2 Cardiac diseases
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Respiratory diseases
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation Market, By Patient Population

  • 6.1 Key segment trends
  • 6.2 Infant
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Pediatric
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Adult
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.2.2 Market size, by modality, 2016 - 2027 (USD Mn)
    • 7.2.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.2.4 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.2.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.2.5.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.2.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.2.6.3 Market size, by patient population, 2016 - 2027 (USD Mn)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.3.2 Market size, by modality, 2016 - 2027 (USD Mn)
    • 7.3.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.3.4 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.3.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.5.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.3.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.6.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.3.7 France
      • 7.3.7.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.3.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.7.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.3.8.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.8.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.3.9.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.9.3 Market size, by patient population, 2016 - 2027 (USD Mn)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.4.2 Market size, by modality, 2016 - 2027 (USD Mn)
    • 7.4.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.4.4 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.4.5 China
      • 7.4.5.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.4.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.5.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.4.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.6.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.4.7 India
      • 7.4.7.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.4.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.7.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.4.8 Taiwan
      • 7.4.8.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.4.8.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.8.3 Market size, by patient population, 2016 - 2027 (USD Mn)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.5.2 Market size, by modality, 2016 - 2027 (USD Mn)
    • 7.5.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.5.4 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.5.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.5.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.5.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.6.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.5.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.7.3 Market size, by patient population, 2016 - 2027 (USD Mn)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.6.2 Market size, by modality, 2016 - 2027 (USD Mn)
    • 7.6.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.6.4 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.6.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.5.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.6.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.6.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.6.7 Qatar
      • 7.6.7.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.6.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.7.3 Market size, by patient population, 2016 - 2027 (USD Mn)
    • 7.6.8 UAE
      • 7.6.8.1 Market size, by Modality, 2016 - 2027 (USD Mn)
      • 7.6.8.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.8.3 Market size, by patient population, 2016 - 2027 (USD Mn)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 Abbott Laboratories
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Alung Technologies
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Braile Biomedical
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Edwards Lifesciences Corp
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Elsius Biomedical Inc
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Eurosets Srl
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Getinge Group
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 LivaNOVA PLC
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Medtronic
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 MicroPort Scientific Corporation
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Nipro Corporation
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Original Biomedical
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Spectrum Medical
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Terumo Corporation
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis